share_log

Wedbush Reiterates Outperform on Travere Therapeutics, Maintains $13 Price Target

Wedbush Reiterates Outperform on Travere Therapeutics, Maintains $13 Price Target

Wedbush重申Travere Therapeutics的跑赢大盘,维持13美元的目标股价
Moomoo 24/7 ·  04/17 13:23

Wedbush analyst Laura Chico reiterates Travere Therapeutics (NASDAQ:TVTX) with a Outperform and maintains $13 price target.

Wedbush分析师劳拉·奇科重申了Travere Therapeutics(纳斯达克股票代码:TVTX)的跑赢大盘,并维持13美元的目标股价。

声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息
    抢沙发